Drugmakers will start vaccine production by end of summer, Trump health officials say

spike

In this May 4, 2020 photo provided by the University of Maryland School of Medicine, the first patient enrolled in Pfizer’s COVID-19 coronavirus vaccine clinical trial at the University of Maryland School of Medicine in Baltimore, receives an injection.

University of Maryland School of Medicine | AP

U.S. health officials and drugmakers expect to start producing potential coronavirus vaccine doses by the end of the summer, a senior administration official said Monday.

The U.S. is aiming to deliver 300 million doses of a vaccine for Covid-19 by early 2021. The manufacturing process is already underway even though they aren’t sure

Read More

Fears of coronavirus second wave prompt flu push at U.S. pharmacies, drugmakers

spike

NEW YORK (Reuters) – U.S. pharmacy chains are preparing a big push for flu vaccinations when the season kicks off in October, hoping to curb tens of thousands of serious cases that could coincide with a second wave of coronavirus infections.

FILE PHOTO: A nurse displays a flu vaccine at a free medical and dental health clinic in Los Angeles, California, U.S., April 27, 2016. REUTERS/Lucy Nicholson

CVS Health Corp (CVS.N), one of the largest U.S. pharmacies, said it is working to ensure it has vaccine doses available for an anticipated surge in customers seeking shots to protect

Read More